Improved Lung Delivery of Medical Aerosols through Enhanced Condensation Growth
通过增强冷凝增长改善医用气雾剂的肺部输送
基本信息
- 批准号:7573264
- 负责人:
- 金额:$ 21.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-10 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAerosolsAirAir ConditioningAlbuterolAlbuterol SulfateAnimalsBenignBreathingBronchiComputer SimulationCouplingCromolyn SodiumCystic FibrosisDataDepositionDevelopmentDevicesDiabetes MellitusDistalDoseDrug Delivery SystemsEffectivenessElementsEnvironmentEvaluationExhalationFutureGasesGenerationsGoalsGrowthGuidelinesHeatingHousingHumanHumidifierHumidityIn VitroInsulinIsotonic ExerciseJointsLiquid substanceLungLung diseasesMalignant neoplasm of lungMeasuresMedicalMedicineMethodsModelingOral cavityOutcomePharmaceutical PreparationsPharmacologic SubstancePharyngeal structurePhasePhysical condensationPropertyProteinsRelative (related person)ReportingResearchRespiratory SystemRespiratory Tract InfectionsRespiratory tract structureSample SizeSimulateSolidSolutionsSourceSpecific qualifier valueSystemTechniquesTemperatureTestingTherapeuticTracheobronchialUpper respiratory tractValidationWateraqueousbasechronic painconditioningdensitydesignimprovedin vitro Modelin vivoinsightinterestnanoparticlenew technologynext generationnovelparticlephysical propertypublic health relevanceresearch studyrespiratorytherapy developmentwater solutionwater vapor
项目摘要
DESCRIPTION (provided by applicant): Inhaled pharmaceutical aerosols are often deposited in the lung at very low deposition efficiencies. Perhaps more significant than the quantity of drug deposited is the large inter- and intra-subject variability that is often observed with these medicinal aerosols and the associated dose delivered to the lung. In order to make many next-generation inhaled medications a viable drug delivery alternative, increased lung delivery and decreased inter- and intra-subject variability are of critical importance. The objective of this study is to develop an approach for improved lung delivery and retention of nanoparticle and submicrometer aerosols using enhanced condensation growth. This concept consists of combining (1) a controlled inhalable water vapor humidity source with (2) a submicrometer aerosol generation and delivery device. The humidity source is used to create a controlled supersaturated relative humidity environment within general regions of the lung. This conditioning of the respiratory tract may be accomplished through an inhalation of supersaturated water vapor with pre-specified temperature and relative humidity (RH) conditions. The aerosol, in particle or droplet form, will be delivered either concurrently or following the controlled inhalation of the humidity source. The aerosol should have a size that can effectively penetrate the mouth-throat and upper tracheobronchial regions, e.g., approximately 1 ¿m and below. Upon transport into the lung, the aerosol will increase in size due to enhanced condensation growth (water accumulation) in the controlled supersaturated environment, thereby increasing retention. To achieve this objective, the following specific aims are proposed: Specific Aim 1: Develop an in vitro system to evaluate the controlled enhanced condensation growth concept in the upper respiratory tract and assess the effects of RH under steady flow conditions. Specific Aim 2: Develop and validate a computational fluid dynamics (CFD) model of hygroscopic droplet growth in the upper tracheobronchial region and apply the model to evaluate aqueous wall boundary conditions and transport into distal bronchi. Specific Aim 3: Employ the developed in vitro and CFD models to test the effects of (1) transient flow, (2) aerosol concentration density, and (3) aerosol hygroscopic properties and physical form on the hygroscopic growth of 100 - 1000 nm aerosols. By delivering submicrometer aerosols past the mouth-throat and then increasing aerosol size through enhanced condensation growth, significant reductions in upper airway deposition and increased lung retention are expected. As a result, reduced variability in dose can be achieved, which is necessary for the effective use of many next-generation pharmaceutical aerosols.
Public Health Relevance: A number of inhalable medications are in development for the treatment of respiratory diseases (such as lung cancer, respiratory infections, and cystic fibrosis) and systemic conditions (such as diabetes, chronic pain, and growth deficiency). However, the delivery of these next- generation inhaled pharmaceuticals to the lungs is often inefficient, which can significantly reduce drug effectiveness and increases unwanted side effects. The overall goal of this project is to develop a novel technology for the efficient delivery of inhaled medicines that minimizes deposition in the mouth and throat and maximizes deposition in the lungs.
描述(由申请人提供):吸入的药物气雾剂通常以非常低的沉积效率沉积在肺中。也许比药物沉积的数量更重要的是,这些药物气雾剂和相关的肺部剂量经常出现巨大的受试者间和受试者内的差异。为了使许多下一代吸入性药物成为可行的给药选择,增加肺部给药和减少受试者间和受试者内的变异性至关重要。这项研究的目的是开发一种利用增强凝结生长来改善纳米颗粒和亚微米气雾剂的肺递送和滞留的方法。这一概念包括(1)受控可吸入水蒸气湿度源与(2)亚微米气溶胶产生和输送装置的结合。湿度源用于在肺部的一般区域内创建受控的过饱和相对湿度环境。呼吸道的这种调节可以通过吸入具有预先规定的温度和相对湿度(RH)条件的过饱和水蒸气来完成。气雾剂,以颗粒或液滴的形式,将同时或在受控吸入湿度源之后输送。气雾剂的大小应能有效地穿透口腔-喉咙和上气管-支气管区,例如大约1?m及以下。在进入肺部后,由于受控过饱和环境中的凝结生长(水分积累)增强,气溶胶的尺寸将增大,从而增加滞留。为了实现这一目标,提出了以下具体目标:具体目标1:建立一个体外系统,以评估受控强化凝结生长概念在上呼吸道的概念,并评估在稳定流动条件下RH的效果。具体目标2:开发和验证吸湿性液滴在上气管、支气管区生长的计算流体动力学(CFD)模型,并应用该模型评估房水壁边界条件和向远端支气管的传输。具体目标3:使用开发的体外和CFD模型来测试(1)瞬变流动,(2)气溶胶浓度密度,(3)气溶胶吸湿特性和物理形态对100-1000 nm气溶胶吸湿生长的影响。通过将亚微米气雾剂输送到口腔-喉咙,然后通过增强凝结生长来增加气雾剂的尺寸,预计可以显著减少上呼吸道沉积和增加肺滞留。因此,可以减少剂量的可变性,这对于许多下一代药物气雾剂的有效使用是必要的。
公共卫生相关性:一些可吸入药物正在开发中,用于治疗呼吸系统疾病(如肺癌、呼吸道感染和囊性纤维化)和全身疾病(如糖尿病、慢性疼痛和生长缺陷)。然而,这些下一代吸入型药物进入肺部的效率往往很低,这可能会显著降低药物有效性,并增加不想要的副作用。该项目的总体目标是开发一种新的技术,以有效地提供吸入药物,最大限度地减少口腔和喉咙中的沉积,并最大限度地增加肺部中的沉积。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
P. Worth Longest其他文献
P. Worth Longest的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('P. Worth Longest', 18)}}的其他基金
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
- 批准号:
10658610 - 财政年份:2023
- 资助金额:
$ 21.42万 - 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
- 批准号:
10704308 - 财政年份:2022
- 资助金额:
$ 21.42万 - 项目类别:
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Metered Dose Inhalers
计算流体动力学 (CFD) 模型有助于通用计量吸入器的开发
- 批准号:
10372282 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Metered Dose Inhalers
计算流体动力学 (CFD) 模型有助于通用计量吸入器的开发
- 批准号:
10459405 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Metered Dose Inhalers
计算流体动力学 (CFD) 模型有助于通用计量吸入器的开发
- 批准号:
10898102 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug
口服吸入药物安全性和有效性的预测肺沉积模型
- 批准号:
8922803 - 财政年份:2012
- 资助金额:
$ 21.42万 - 项目类别:
Nanoaerosols from Wick Electrospray for Improved Drug Delivery to Infants
来自灯芯电喷雾的纳米气溶胶可改善婴儿的药物输送
- 批准号:
8358410 - 财政年份:2012
- 资助金额:
$ 21.42万 - 项目类别:
Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug
口服吸入药物安全性和有效性的预测肺沉积模型
- 批准号:
8485977 - 财政年份:2012
- 资助金额:
$ 21.42万 - 项目类别:
Nanoaerosols from Wick Electrospray for Improved Drug Delivery to Infants
来自灯芯电喷雾的纳米气溶胶可改善婴儿的药物输送
- 批准号:
8520366 - 财政年份:2012
- 资助金额:
$ 21.42万 - 项目类别:
Improved Lung Delivery of Medical Aerosols through Enhanced Condensation Growth
通过增强冷凝增长改善医用气雾剂的肺部输送
- 批准号:
7760144 - 财政年份:2009
- 资助金额:
$ 21.42万 - 项目类别:
相似海外基金
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
- 批准号:
10092043 - 财政年份:2024
- 资助金额:
$ 21.42万 - 项目类别:
EU-Funded
Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
开发手持式快速空气传感系统,实时监测和量化气溶胶中的 SARS-CoV-2
- 批准号:
10854070 - 财政年份:2023
- 资助金额:
$ 21.42万 - 项目类别:
Multispectral Sensor for Chemical Composition Analysis of Ultrafine Aerosols in Air Quality Assessment
用于空气质量评估中超细气溶胶化学成分分析的多光谱传感器
- 批准号:
10546675 - 财政年份:2022
- 资助金额:
$ 21.42万 - 项目类别:
Experimental Validation of CFD Modeling of Aerosols in Aircraft Cabins Considering Heating Ventilation and Air Conditioning (HVAC) Systems for COVID-19 & other Airborne Diseases
考虑适用于 COVID-19 的供暖通风和空调 (HVAC) 系统的机舱内气溶胶 CFD 建模的实验验证
- 批准号:
570756-2021 - 财政年份:2022
- 资助金额:
$ 21.42万 - 项目类别:
Alliance Grants
Multispectral Sensor for Chemical Composition Analysis of Ultrafine Aerosols in Air Quality Assessment
用于空气质量评估中超细气溶胶化学成分分析的多光谱传感器
- 批准号:
10887673 - 财政年份:2022
- 资助金额:
$ 21.42万 - 项目类别:
Using satellites to map the spatial characteristics of urban air pollution from aerosols at a time of climate change, health choices and pandemics
利用卫星绘制气候变化、健康选择和流行病时期城市气溶胶空气污染的空间特征
- 批准号:
2609674 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Studentship
CINDAER Composition of indoor aerosols and their role in air quality
CINDAER 室内气溶胶的成分及其对空气质量的作用
- 批准号:
2599050 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Studentship
Experimental Validation of CFD Modeling of Aerosols in Aircraft Cabins Considering Heating Ventilation and Air Conditioning (HVAC) Systems for COVID-19 & other Airborne Diseases
考虑适用于 COVID-19 的供暖通风和空调 (HVAC) 系统的机舱内气溶胶 CFD 建模的实验验证
- 批准号:
570756-2021 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Alliance Grants
Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time
开发手持式快速空气传感系统,实时监测和量化气溶胶中的 SARS-CoV-2
- 批准号:
10273983 - 财政年份:2021
- 资助金额:
$ 21.42万 - 项目类别:
Biomass Burning Flux Measurements of Trace Gases and Aerosols (BB-FLUX) Using Solar Occultation Flux (SOF) on the Wyoming King Air
使用怀俄明 King Air 上的太阳掩星通量 (SOF) 测量微量气体和气溶胶 (BB-FLUX) 的生物质燃烧通量
- 批准号:
1754019 - 财政年份:2018
- 资助金额:
$ 21.42万 - 项目类别:
Continuing Grant














{{item.name}}会员




